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Abstract
It is critical to include a sexual and reproductive health lens in HIV programming as most HIV transmission occurs
through sexual intercourse. As global attention is focusing on the sexual and reproductive health needs of women
living with HIV, identifying which interventions work becomes vitally important. What evidence exists to support
sexual and reproductive health programming related to HIV programmes?
This article reviews the evidence of what works to meet the sexual and reproductive health needs of women living
with HIV in developing countries and includes 35 studies and evaluations of eight general interventions using
various methods of implementation science from 15 countries. Data are primarily from 2000-2009. Searches to
identify effective evaluations used SCOPUS, Popline, Medline, websites and consultations with experts. Evidence
was ranked using the Gray Scale.
A range of successful and promising interventions to improve the sexual and reproductive health and rights of
women living with HIV include: providing contraceptives and family planning counselling as part of HIV services;
ensuring early postpartum visits providing family planning and HIV information and services; providing youth-
friendly services; supporting information and skills building; supporting disclosure; providing cervical cancer
screening; and promoting condom use for dual protection against pregnancy and HIV. Provision of antiretrovirals
can also increase protective behaviours, including condom use.
While many gaps in programming and research remain, much can be done now to operationalize evidence-based
effective interventions to meet the sexual and reproductive health needs of women living with HIV.
Review
Meeting women’s sexual and reproductive health (SRH)
needs ensures women have control over their reproductive
lives, as well as contributes to public health by reducing
maternal and infant morbidity and mortality [1]. Yet the
SRH needs of women are compelling: 215 million women
in the developing world have an unmet need for family
planning [2]. Women who have unintended pregnancies
are affected by biological outcomes, such as increased
maternal morbidity and mortality, as well as social out-
comes, such as stigma. Of the 215 million women with an
unmet need for family planning, it is unclear how many
are HIV positive or of unknown serostatus.
Women living with HIV, as well as HIV-negative
women, would benefit from interventions that meet their
SRH needs and reduce unintended pregnancies, reduce
HIV transmission and acquisition, and reduce reproduc-
tive morbidity and mortality. One study found that
HIV-positive women are five times more likely to have a
high-risk type of human papillomavirus (HPV) [3], and
therefore are at increased risk of cervical cancer.
Further, a study in Uganda found that unintended
pregnancies may account for almost a quarter of all
HIV-positive infants in that country [4]. A 2008 model-
ling study in the 15 US President’s Emergency Plan for
A I D SR e l i e f( P E P F A R )c o u n t r i e se s t i m a t e dt h a tt h e
annual number of unintended HIV-positive births
averted by contraception use is more than 220,000 [5].
As a sexually transmitted infection, HIV is inextricably
linked with women’s sexual and reproductive health; at
least half of the 2.6 million new infections globally in
2009 were among women [6]. Unfortunately, discussions
of SRH services for women living with HIV often revolve
around controlling fertility and ignore HIV-positive
women’s needs for services that include attention to safe
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living with HIV must “have the right to decide freely and
responsibly on the number and spacing of their children”
[7].
Over the past several years, a number of international
agencies have called for stronger links between reproduc-
tive health and family planning and HIV/AIDS pro-
grammes and services [8,9] and have issued guidance on
linkages and integration within global AIDS programmes
[10-13]. As global attention is focusing on the SRH needs
of women living with HIV, identifying which interventions
work to meet those needs becomes vitally important. With
scarce resources and growing demand for services, pro-
gramme priorities must be based on effective interven-
tions. One key question, therefore, must be answered:
what is the evidence for effective interventions to meet the
SRH needs of women living with HIV?
This paper reviews successful and promising interven-
tions to meet the SRH needs of women and girls living
with HIV, based on a more extensive review of the evi-
dence to support interventions for women and girls
related to all aspects of HIV and AIDS programming [14].
This review article focuses on SRH interventions for
women living with HIV based largely on research and pro-
gramme evaluations conducted in developing country set-
tings, so as to be most relevant for developing country
settings. Realistic interventions may differ between
resource-rich and resource-poor settings.
The paper: 1) analyzes the breadth of interventions and
the strength of the evidence; 2) describes successful and
promising interventions to reduce unintended pregnancy,
to reduce HIV transmission, and to reduce reproductive
morbidity and mortality; and 3) provides recommenda-
tions for strengthening programmes to meet SRH needs.
Our approach
The review focused on areas of SRH that are of critical
concern to women living with HIV in developing coun-
tries: reducing unintended pregnancy; promoting safer sex
and the ability of HIV-positive women to have wanted
children while reducing the likelihood of transmission to a
sexual partner (which includes issues of disclosure); and
reducing the incidence of cervical cancer in HIV-positive
women. Safe motherhood, including use of antenatal,
delivery and postnatal care, and prevention of vertical
transmission of HIV is a critical issue in the sexual and
reproductive rights of women living with HIV, but it is
outside the scope of this paper.
To search for relevant interventions, SCOPUS [15]
searches were conducted for 2005-2009 using the search
words HIV or AIDS and wom*n, and other specific
terms, including “sexual rights and HIV"; “sexual health
and HIV"; family planning and HIV"; “contraception and
HIV"; and “cervical cancer and HIV.” Earlier material was
identified using the same search terms in Popline and
Medline. In addition, the gray literature was captured
through review of websites: Center for Reproductive
Rights; Engenderhealth; FHI360; Guttmacher Institute;
HRW; ICW; International HIV/AIDS Alliance; IPAS;
I P P F ;N I H ;O S I ,P A I ;U N A I D S ,a n dW H O .I na d d i t i o n ,
experts were consulted on each topic, both to ensure
complete coverage of the topic and to review the evi-
dence included in the analysis. Altogether, more than
sixty experts were consulted on comprehensiveness,
applicability and accuracy; experts included researchers
who had published widely on this topic, women living
with HIV who belong to advocacy organizations, policy-
makers, program managers and donors. Those who
attended a review meeting were asked 10 questions
related to the evidence in the chapters they were review-
ing. Other experts were sought out to provide technical
detail and understanding; those questions were tailored
for their area of expertise and to the outstanding queries
of the authors. To be included in this review, the SRH
interventions had to have an evaluation (either the inter-
vention was part of a study or it was subject to an evalua-
tion) with outcomes reported with sex-disaggregated
data, where relevant.
Evidence was rated using the Gray Scale [16], which
lists five levels of evidence, with I being the strongest and
V the weakest (Table 1). In the case of conference
abstracts, only abstracts from recent AIDS and family
planning conferences were included and only abstracts of
strong studies that, once published, will likely be Gray I,
II or III. Criteria set for “what works,” and “promising”
interventions, shown in Table 2 were determined by an
expert review panel [14].
This review includes 35 studies and/or evaluations
grouped under eight interventions (Table 3). Of the eight
interventions, six fall under the category of what works,
w h i l et w of a l li n t ot h ec a t e g o r yo fp r o m i s i n g .T h ei n t e r -
ventions included evidence from 15 individual countries,
all in Africa, Latin America and the Caribbean, and the
US, as well as from analyses of multiple countries and
regions (Table 3).
Interventions that work
Promoting contraceptives and family planning counselling
as part of routine HIV services and vice versa
Eleven studies and/or evaluations (see Table 3) provided
evidence that promoting contraceptives and family plan-
ning as a routine part of HIV services (and vice versa)
may increase condom use, contraceptive use and dual
method use [17-27]. Providing these integrated services
can avert unintended pregnancies among women living
with HIV. For example, successful outcomes have been
demonstrated in Haiti and Zambia using family planning
education, offering contraceptives on site at a voluntary
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ling and provision of free contraceptives, as well as invol-
ving male partners in discussions of unintended
pregnancies and integration of services [17,19].
In Haiti, GHESKIO (The Haitian Group for the Study of
Kaposi’s Sarcoma and Opportunistic Infections, a non-
governmental organization providing training, research
and services) integrated VCT and family planning services
in one central HIV clinic. At 18 months, 74% of the 348
HIV-positive mothers in the study were using family plan-
ning services compared with 23% of women in the general
population [19]. A three-arm randomized trial at a VCT
clinic in Lusaka, Zambia, with 251 couples found a three-
fold higher contraceptive initiation rate where family plan-
ning was available on site, rather than by referral to an
outside clinic [17].
Because many people still do not know their HIV status,
and because negotiating condom use is not always possi-
ble, expanding access to a range of contraceptives for all
women who need and want them is an important compo-
nent of HIV programming, and it is cost effective [28,29].
In providing integrated services, both providers and cli-
ents need up-to-date information on contraceptives and
HIV. No current method of contraception protects against
HIV transmission; contraception and condom use together
can provide the best “dual protection” against conception
and HIV transmission. Over the years, questions have
arisen about the safety of use of hormonal contraceptives
by women living with HIV and whether any contraceptive
methods increase the risk of HIV acquisition. Multi-coun-
try reviews found that hormonal and intrauterine methods
of contraception were generally well tolerated by women
with HIV [30] and found no association between hormo-
nal contraceptive use and HIV disease progression [31].
A study in Uganda of 625 women with 13 years of fol-
low up found no association between hormonal contra-
ception and increased risk of death for women living
with HIV [32]. A review performed by an independent
expert group using 1000 references related to IUDs
found no known drug interactions between IUDs and
highly active antiretroviral therapy (HAART) [33]. The
review also determined that there appears to be no
increase in overall complications, although HIV-positive
women need to be screened for sexually transmitted
infections with IUDs [33]. There was no increased risk of
transmission to HIV-negative partners by HIV-positive
IUD users.
Biological and epidemiological data have suggested that
hormonal contraceptive use could influence HIV acquisi-
tion, but not all studies have shown this relationship and
“many questions remain” [34]. A re-analysis of earlier data
using more sophisticated modeling found that DPMA use
was marginally associated with an increased risk of HIV
acquisition while oral contraceptive use was not; however,
young women under age 24 using DPMA were at
increased risk of HIV acquisition [35]. A recent analysis of
data from east and southern Africa from the Partners in
Prevention HSV/HIV Transmission Study found an ele-
vated risk of HIV acquisition for women and transmission
from women to men, with hormonal contraceptive use
[36]. The World Health Organization (WHO) is conven-
ing a technical review meeting of hormonal contraception
and HIV in January 2012. Until the evidence is further
evaluated, WHO’s Medical Eligibility Criteria for Contra-
ceptive Use recommends that the benefits of hormonal
contraceptive use outweigh any potential harm for women
at high risk of and living with HIV [37].
Early postpartum visits that include FP and HIV information
and services
Contraception counselling for women in order to space
their next pregnancy or prevent an unintended pregnancy
is a critical component of postpartum care. Evaluations of
interventions in three countries showed that postpartum
services can result in increased condom and contraceptive
use, HIV testing and treatment, and reduced unintended
pregnancy [38-40]. In Swaziland, a study with 356 postpar-
tum women and 53 healthcare workers that instituted a
one week post-delivery postpartum visit along with
Table 1 Gray scale of the strength of evidence
Type Strength of evidence
I Strong evidence from at least one systematic review of multiple well-designed, randomized controlled trials.
II Strong evidence from at least one properly designed, randomized controlled trial of appropriate size.
III Evidence from well-designed trials without randomization: single, group, pre-post, cohort, time series, or matched case-control studies.
IV Evidence from well-designed, non-experimental studies from more than one centre or research group.
V Opinions of respected authorities, based on clinical evidence, descriptive studies or reports of expert committees.
Table 2 Criteria for “what works” and “promising” Interventions
Type Criteria
What works Strongly rated studies (Gray I, II or III) for at least two countries and/or five weaker studies across multiple settings.
Promising Studies that were strongly rated but in only one setting or a number of weaker studies in only one country.
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Intervention Outcomes Reference Country G* Description
Contraception/
FP as part of routine








[17] Zambia II FP^ education and offer of contraceptives available on site
rather than by referral.
[18] South Africa II Integrated routine discussion of HIV risk and prevention, dual
method use and increased counselling and testing in FP
services.
[19] Haiti III Rapid HIV testing performed on all pregnant women. After
testing, all HIV-positive, pregnant women informed of their
status, counselled and referred to ANC clinic. Voluntary
counselling and testing (VCT), sexually transmitted infections
(STIs), family planning (FP) services and TB screening and
treatment integrated into one central HIV clinic.
[20] Kenya III Trained staff on contraceptive methods with job aids to use
with clients; provision of free contraceptive methods;
appointment cards; discussions with couples; involvement of
male partners in discussions; and discussions of unintended
pregnancies.
[21] Kenya III Provider-initiated testing and counselling with updated
guidelines to discuss HIV transmission, conduct risk assessment,
discuss dual protection, and offer testing and counselling. Staff
training included contraception, HIV, reproductive rights,
informed choice, safe sex, values clarification, risk assessment
and reduction, record keeping and logistics.
[22] Nigeria III Integration of FP and HIV services, with strengthened referral
links, provider training, co-located services, same staff and
parallel supply chain management systems and strong
monitoring and evaluation.
[23] Uganda III FP was integrated into HIV treatment, using an integrated
training curriculum. Short-term contraceptives were available on
site with referral for long-term and permanent methods.
[24] Uganda IV Access to contraception and linking FP services for women on
HAART.
[25] Uganda V Easy access to FP services for HIV-positive women accessing
HAART services
[26] Malawi V Providing on-site FP services to women participating in HIV-
related research studies.
[27] South Africa V Women initiating ART also counselled on effective
contraception, provided through referral to a nearby primary
care clinic.
Early postpartum








[38] Swaziland III One week postpartum visit for HIV-positive mothers, with
provider training on FP.
[39] Kenya III Postpartum follow up for HIV-positive women, with referral for
contraceptive counselling and services. The women were
counselled antenatally to initiate contraception postpartum and
dual protection.
[40] Cote d’Ivoire III Women tested for HIV prenatally were followed up for two
years following delivery. At each postpartum visit, women








[41] Multi-country III A review of HIV prevention interventions among youth from 80
developing countries.
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[42] Mozambique III Youth-friendly clinical services as part of a multidisciplinary
approach that include no-cost FP counselling and
contraceptives and HIV counselling and testing.
[43] Madagascar III Offer of confidential, convenient and affordable HIV testing, FP
and STI treatment services by non-judgmental providers.
Promotion of the clinics through mass media, face-to-face





Reduce unprotected sex [44] USA I A meta-analytic review of 12 trials in the US. All interventions
provided information with nine interventions providing skill
building through live demonstrations, role plays or practice,
such as correct use of condoms, coping or interpersonal skills,
such as communication about safer sex or disclosing serostatus.
Interventions were delivered by healthcare providers,
counsellors or trained HIV-positive peers. Effective interventions
were delivered on a one-to-one basis by providers or
counsellors with at least 10 intervention sessions for at least
three months. No studies which met the meta-analytic criteria
were found for developing country contexts.
[45] Multi-country I A meta-analysis found that the most effective interventions
included skills-building and motivated participants.
[46] Multi-
country
III A review of interventions for “prevention for positives” included:
individually delivered intervention sessions; group sessions,
including a focus on gender and sexual orientation; attention
to negative consequences of unsafe sex for the HIV-positive
person; interactive group sessions and social networking.
Addressing provider attitudes and providing training to
providers was found to be critical.
[47] Zambia V Focus group sessions for women with skills training on HIV
prevention and transmission, communication, conflict resolution
and sexual negotiation.
Supporting disclosure Increase condom use
among discordant
couples
[48] South Africa IV To assess outcomes associated with disclosure, including safer
sexual behaviour.
[49] Uganda Abs A programme by The AIDS Support Organization (TASO) to
provide support that resulted in sero-disclosure.
[50] Caribbean
Region
Abs Assessed disclosure and relevant outcomes, including condom
use.
Providing ARVs Increase prevention
behaviours, including
condom use
[53] Uganda III Study participants were followed in a home-based ART
programme that included prevention counselling, VCT for
cohabitating partners and condom provision.
[54] Uganda III A prospective cohort of HIV-negative household members of
HIV-positive patients on ART receiving home-based care.
[55] Kenya III A comparative study of people living with HIV or AIDS on
HAART and those receiving preventative therapy (PT), including
such outcomes as condom use.
[56] Uganda III Condom use among ART patients compared with non-ART
patients.
[57] Multi-country III To assess outcomes among ART patients compared with non-
ART patients, including condom use.
[58] Rwanda and
Zambia
IV A study of longitudinal data from sero-discordant couples,




IV Analysis of survey data of HIV-positive women in three
countries, including HAART and condom use.
[60] Mozambique IV A survey of HIV care clinic attendees from initiation to
treatment, including condom use.
Promising
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portion of HIV-positive postpartum women not wanting
another child increased from 77% to 83% [38]. Provider
training increased the proportion of women being asked
about their preferred contraceptive method, from 32% to
82%, and receiving their preferred method, from 28% to
70%. Male partners who tested for HIV increased from
28% to 56%.
Providing clinic services that are youth friendly
Young people’s service needs are frequently overlooked in
HIV programming that is not specifically for young peo-
ple. A review in 80 developing countries found that youth-
friendly services increased young people’su s eo fh e a l t h
services [41]. Interventions in two countries, Mozambique
and Madagascar, show that services that include confiden-
tial, non-judgemental, convenient and affordable HIV test-
ing and counselling and family planning information and
services can increase use of services by youth [42,43].
Providing information and skills-building support can
reduce unprotected sex
Most data on this topic come from the United States
[44-47]. Only one of the studies was with HIV-positive
women only, and this was in Zambia [47]. A meta-analy-
tic review of 12 randomized trials in the USA found
interventions (described in Table 3) that are effective in
reducing unprotected sex and acquisition of sexually
transmitted infections among people living with HIV
[44]. A meta-analysis of 14 articles with studies that
included 3324 HIV-positive people, most in the USA,
found that motivational and behavioural skills building
concerning sexual risks increased condom use [45].
A number of studies in the USA also found that inter-
active group sessions, frequency of counselling and dis-
closure reduced unprotected sex [46]. In the developing
world, one study in Zambia with 180 women found
safer sex skills training on HIV prevention and transmis-
sion, communication, conflict resolution and sexual
negotiation resulted in female participants reporting
increased condom use, with 94% of the women report-
ing using condoms all of the time [47].
Supporting disclosure can increase safer sexual behaviour
Three studies in the review showed that women who
feel support for disclosure exhibit safer sexual beha-
viours [48-50]. For example, one study in South Africa
f o u n dt h a ta m o n g1 7 7H I V - p o s i t i v ep e o p l ew h od i s -
closed, perceived support for disclosure led to safer sex-
ual behaviour: 82% asked their partners to get tested,
64% used condoms, 56% reduced their numbers of sex-
ual partners, and 20% abstained from sex. Family mem-
bers and providers were the main sources of social
support [48].
Providing ARVs and counselling increases HIV prevention
behaviours
Studies, including modeling, have shown that antiretro-
viral (ARV) therapy reduces HIV transmission [51,52]. A
study assessing HIV transmission among 1763 serodis-
cordant couples where the HIV-positive partner was
initiated on ARV therapy when CD4+ counts were
between 350 and 500 cells/mm
3 showed such compelling
results that it was stopped early. The study showed a 96%
reduction in transmission to the HIV-negative partner
[52]. Eight studies in this review show that providing
Table 3 Evidence to support interventions for promoting the sexual and reproductive health of women living with





mortality in women living
with HIV
[63] Zambia V A programme for cervical cancer for both HIV-positive and HIV-
negative women that screened more than 20,000 women and
linked cervical cancer prevention services with HIV care and
treatment services. Cervical cancer using visual inspection with
acetic acid (VIA) provided on-the-spot results, which were then
linked with same-visit cryotherapy. Peer educators reduced loss
to follow up. Community women were trained on conducting
community-based cervical health promotion talks. Women who
wanted more information were directed to the cervical cancer
prevention clinics. To minimize stigma, screening clinics were
co-located in government-operated public health clinics near to
but not directly within the HIV clinic.
[64] NA V A new, rapid HPV test is underway and may be the best option
considering the difficulties associated with Pap smears, visual
inspection and HPV tests in low-resource countries. Questions
remain on effectiveness in HIV-positive women.
Promoting condom
use for contraception
Make condom use more
acceptable and easier to
negotiate
[65] Ethiopia III A study that included assessment of use of condoms and
reasons for condom use among sex workers.
Total 35
* G = Gray Scale Rating of the Strength of the Evidence (see Table 1)
^ FP = family planning
Abs = abstract
Gay et al. Journal of the International AIDS Society 2011, 14:56
http://www.jiasociety.org/content/14/1/56
Page 6 of 10antiretroviral treatment to people living with HIV, along
with counselling on safer sex, can increase HIV preven-
tion behaviours, including condom use [53-60]. For
example, a study in Uganda found that within six months
of initiating ART, inconsistent or no condom use was
reduced by 70% [53].
Another study in Uganda of 182 men and 273 women
found that both men and women on antiretroviral ther-
apy (ART) reduced inconsistent condom use from 29%
to 15%. Among women, risky sex decreased from 31% at
baseline to 10% at six months and 15% at 24 months;
among men, risky sex decreased from 30% at baseline to
8% at six months and 13% at 24 months [54]. Analysis of
survey data of 85 HIV-positive women from Uganda, 50
HIV-positive women from South Africa and 44 HIV-
positive women from Brazil found that HAART users
were 3.64 times more likely to use condoms [59]. A sur-
vey of 277 patients in Mozambique found that after one
year of ART, 77% were more likely to report correct and
consistent condom use compared with 33% prior to
initiation [60]. The study also showed the need to con-
tinue prevention messages as both men and women had
an increase in the number of partners, including partners
with HIV-negative or unknown serostatus.
Promising strategies
Cervical cancer screening and treatment can be integrated
into HIV care
Women living with HIV are at high risk of developing
cervical cancer [61], yet coverage for screening in many
developing countries is low [62]. While only reaching
the level of promising evidence, a programme in Zambia
screened 20,000 women in 15 primary care clinics and
linked cervical cancer prevention services with HIV
treatment and care [63]. Another study suggests that
cervical cancer screening of HIV-positive women in
low-resource countries could be integrated with ARV
treatment, as ART programmes have established the
regular observation, infrastructure and services to sup-
port cervical cancer screenings. Development of a new,
rapid HPV test is underway and may be the best option
considering the difficulties associated with Pap smears,
visual inspection and HPV tests in low-resource coun-
tries [64].
Promoting condoms for contraception as well as HIV
prevention may make condoms more acceptable
Promoting condoms for contraception may increase con-
dom use, although clients should also be counselled that
there are other methods of contraception that are more
effective in preventing unintended pregnancy. A study of
372 sex workers in Ethiopia found that those women who
used condoms for contraception were more likely to use
condoms consistently (65% compared with 24%) [65].
Conclusions
Identifying the links between SRH and HIV is a timely
issue: in addition to this analysis [14], several reviews
have recently been published [66,67] and several inter-
national agencies, including the Global Fund to Fight
AIDS, Tuberculosis and Malaria and PEPFAR, have
issued guidance on strengthening ties between repro-
ductive health, family planning and HIV/AIDS pro-
grammes and services.
The evidence reviewed in this paper covers successful
and promising interventions that programmes can imple-
ment to improve the sexual and reproductive health and
rights of women living with HIV. Provision of ARV, criti-
cal for the lives of women living with HIV, can also
increase protective behaviours, including condom use.
Additionally, other effective interventions to help meet the
SRH needs of women living with HIV include: provision
of contraceptives and family planning counselling as part
of HIV services; ensuring that providers and women have
evidence-based information on a range of contraceptive
methods and HIV; supporting information and skills
building; supporting disclosure; providing cervical cancer
screening; and promoting condom use for dual protection
against pregnancy and HIV infection. The evidence base is
supported by studies throughout the world and tends to
rest on well-designed, non-randomized studies (Gray III).
Given that it would not be possible to conduct rando-
mized control trials (Gray II) on many aspects of HIV and
SRH, the level of evidence that exists is sufficiently strong
to promote SRH and HIV programming.
For all that is known about promoting SRH, many gaps
in programming and research remain. A critical gap
remains with the question of hormonal contraception
and HIV. According to Morrison and Nanda, “The ques-
tion of hormonal contraceptive use and risk of HIV
acquisition remains unanswered after more than two
decades ... the time to provide a more definitive answer
to this crucial public health question is now; the donor
community should support a randomized trial of hormo-
nal contraception and HIV acquisition” [68].
More programming is needed to expand access to
contraceptive information and care, provided by trained
providers adhering to rights-based approaches to service
provision. Policies are needed, including those support-
ing integrated services. Other interventions, such as
transforming gender norms, reducing violence against
women, promoting legal rights and increasing employ-
ment opportunities, also need to be implemented in
order to support safer sexual behaviour [14].
The strength of this review is that: these interventions
emerged from a comprehensive review of the evidence;
the evidence was rated using a clear methodology that
was endorsed by a scientific review committee; and the
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tific audiences.
The analysis also contains some limitations. Unsuccess-
ful interventions are not published. Many worthwhile
interventions do not have sex-disaggregated data or are
not thoroughly evaluated, and still others are not pub-
lished in peer-reviewed journals or are not published at
all. Some important work from the gray literature may
have been missed. One weakness of the Gray scale is
prioritizing randomized controlled trials, which are “pri-
marily a vehicle for evaluating biomedical interventions,
rather than strategies to change human behaviour. Alter-
ing the norms and behaviours of social groups can some-
t i m e st a k ec o n s i d e r a b l et i m e. . . ” [69]. Furthermore,
randomized controlled trials are not appropriate for cer-
tain HIV interventions and therefore should not be the
only factor in judging the relative weight of any particular
study. In addition, many HIV prevention programmes that
address key issues in novel, context-specific ways are often
not rigorously evaluated [70].
The interventions highlighted in this review are, for the
most part, implemented on a small scale. It will be impor-
tant to scale up the interventions to reach all relevant
women and girls. The review has identified interventions
that have demonstrated success in certain settings and
particular countries. However, implementation of the
interventions highlighted in this review as “what works” or
“promising” must be contextually specific and culturally
appropriate if they are to be translated to new settings. It
is therefore difficult to be direct about exactly how each of
these interventions will work best (for example, how to
support disclosure). But there is enough evidence to show
that certain ideas and approaches do have a demonstrated
effect on behaviour across multiple settings.
Given that the AIDS epidemic is approaching 30 years,
it time to redouble efforts to ensure that programmes
meet the SRH needs of women living with HIV and to
deepen the evidence base of the most appropriate and
successful interventions to do so [71].
A new generation is now reaching reproductive age,
making the need for strong evidence-based SRH services
as part of HIV programmes all the more critical.
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